These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38514143)

  • 1. Evidence for clinician underprescription of and patient non-adherence to guideline-recommended cardiovascular medications among adults with peripheral artery disease: protocol for a systematic review and meta-analysis.
    de Launay D; Paquet M; Kirkham AM; Graham ID; Fergusson DA; Nagpal SK; Shorr R; Grimshaw JM; Roberts DJ
    BMJ Open; 2024 Mar; 14(3):e076795. PubMed ID: 38514143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for overuse of cardiovascular healthcare services in high-income countries: protocol for a systematic review and meta-analysis.
    Roberts DJ; Sypes EE; Nagpal SK; Niven D; Mamas M; McIsaac DI; van Walraven C; Shorr R; Graham ID; Stelfox HT; Grimshaw J
    BMJ Open; 2022 Apr; 12(4):e053920. PubMed ID: 35393307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
    Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
    J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes After Receipt of Neuraxial or Regional Anesthesia Instead of General Anesthesia for Lower Limb Revascularization Surgery: Protocol for a Systematic Review and Meta-analysis.
    Roberts DJ; Dreksler H; Nagpal SK; Li A; Parsons Leigh J; Brandys T; Jetty P; Dubois L; Stelfox HT; McIsaac DI
    JMIR Res Protoc; 2021 Nov; 10(11):e32170. PubMed ID: 34507273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
    Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V;
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.
    Nastasi DR; Smith JR; Moxon JV; Trollope A; Golledge J
    Stroke; 2018 Dec; 49(12):2953-2960. PubMed ID: 30571405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Surgical Site Infection After Lower Limb Revascularization Surgery in Adults With Peripheral Artery Disease: Protocol for a Systematic Review and Meta-analysis.
    Roberts DJ; Nagpal SK; Stelfox HT; Brandys T; Corrales-Medina V; Dubois L; McIsaac DI
    JMIR Res Protoc; 2021 Sep; 10(9):e28759. PubMed ID: 34161251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic drugs for cardiovascular risk reduction in patients with lower limb peripheral arterial disease: protocol for a systematic review and network meta-analysis of randomised controlled trials.
    Sidebottom DB; Huang C; Carradice D; Holt PJ; John-Pierre K; Roy IN
    BMJ Open; 2023 Aug; 13(8):e072355. PubMed ID: 37562931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.
    Nguyen T; Nguyen HQ; Widyakusuma NN; Nguyen TH; Pham TT; Taxis K
    BMJ Open; 2018 Jan; 8(1):e018271. PubMed ID: 29326185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
    Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
    Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE up the sleeve - are vascular patients medically optimized?
    Coveney AP; O'Brien GC; Fulton GJ
    Vasc Health Risk Manag; 2011 Jan; 7():15-21. PubMed ID: 21339909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease.
    Steenhof N; Le Piane F; Leblanc K; Eisenberg NR; Kwan Y; Malmberg C; Papadopoulos A; Roche-Nagle G
    Vasc Health Risk Manag; 2014; 10():333-40. PubMed ID: 24940068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
    Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
    Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
    Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
    CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.